Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 969 | 1000 | 956 | - | - | - |
Fund Return | -3.11% | 0.04% | -4.35% | - | - | - |
Place in category | 414 | 124 | 573 | - | - | - |
% in Category | 46 | 13 | 73 | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Baillie Gifford American Fund A Acc | 2.93B | 3.19 | -12.95 | 15.40 | ||
Baillie Gifford American Fund B Acc | 2.93B | 3.39 | -12.08 | 16.52 | ||
Baillie Gifford American Fund B Inc | 2.93B | 3.42 | -12.06 | 16.52 | ||
Baillie Gifford Global Alpha Growtb | 2.79B | 8.47 | 1.69 | 12.06 | ||
Baillie Gifford Global Alpha Growth | 2.79B | 8.48 | 1.68 | 12.06 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.88B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.47B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 115.49M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.53B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Acc | 257.33K | 8.14 | 10.01 | 11.74 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shockwave Medical | US82489T1043 | 7.28 | 330.22 | +0.01% | |
Argen-X | NL0010832176 | 7.14 | 350.80 | +0.66% | |
Genmab | DK0010272202 | 6.88 | 1,965.5 | +0.46% | |
Alnylam | US02043Q1076 | 6.03 | 146.44 | +1.73% | |
Moderna | US60770K1079 | 5.73 | 109.14 | -1.06% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review